In a 29‑year‑old patient with a patent ductus arteriosus, does occasional flattening of the interventricular septum during asystole and diastole indicate right‑ventricular pressure and volume overload, and what is the appropriate evaluation and management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interventricular Septal Flattening in PDA: Significance and Management

Yes, occasional flattening of the interventricular septum during diastole in this 29-year-old patient with PDA strongly indicates right ventricular pressure and volume overload, signaling moderate-to-large PDA with pulmonary arterial hypertension that requires urgent hemodynamic assessment and likely warrants PDA closure.

Understanding the Pathophysiology

The diastolic septal flattening you're observing represents a critical hemodynamic marker. In PDA, the typical pathophysiology starts with left-to-right shunting causing LV volume overload 1. However, when moderate or large PDAs persist into adulthood, pulmonary arterial hypertension (PAH) develops, and the clinical picture can shift from predominant LV volume overload to predominant RV pressure overload 1.

The septal flattening during diastole specifically indicates:

  • RV pressure overload causing the interventricular septum to bow toward the LV, creating the characteristic "D-shaped" left ventricle 2, 3
  • This finding correlates strongly with pulmonary hypertension (typically >40-50 mmHg) 2
  • The presence of this sign suggests your patient has progressed beyond simple LV volume overload to significant PAH with RV dysfunction 4

Immediate Diagnostic Algorithm

Step 1: Comprehensive Echocardiographic Assessment

  • Quantify pulmonary artery pressure (PAP) using tricuspid regurgitation jet velocity
  • Measure RV size, function, and wall thickness
  • Assess LV size and ejection fraction
  • Calculate the eccentricity index at end-diastole (normal <1.0; D-shaped LV ≥1.2) 3
  • Document bidirectional vs. unidirectional shunting across the PDA
  • Look for differential cyanosis indicators

Step 2: Oxygen Saturation Measurement Measure oxygen saturation in both hands AND feet to detect right-to-left shunting 5. This is critical because:

  • Upper extremity saturations reflect pre-ductal blood
  • Lower extremity saturations reflect post-ductal blood
  • Differential desaturation indicates shunt reversal (Eisenmenger physiology)

Step 3: Right Heart Catheterization 1 This is mandatory given the echocardiographic evidence of elevated PAP. You must obtain:

  • Mean pulmonary artery pressure (mPAP)
  • Pulmonary vascular resistance (PVR)
  • Systemic vascular resistance (SVR)
  • Pulmonary-to-systemic flow ratio (Qp:Qs)
  • Vasoreactivity testing (preferably with nitric oxide) 1

Treatment Decision Algorithm

The decision to close the PDA depends on specific hemodynamic thresholds:

CLOSE THE PDA (Class I Indication) 1, 5:

  • If PAP <2/3 of systemic pressure AND PVR <2/3 of SVR
  • If there are signs of LV volume overload with net left-to-right shunt
  • If PA systolic pressure <50% systemic AND PVR <1/3 systemic

CONSIDER CLOSURE (Class IIa) 1:

  • If PAP >2/3 systemic OR PVR >2/3 systemic BUT:
    • Net left-to-right shunt persists (Qp:Qs >1.5), AND
    • Vasoreactivity testing demonstrates pulmonary vascular reactivity

DO NOT CLOSE (Class III - Harm) 1, 5:

  • Net right-to-left shunt with PA systolic pressure >2/3 systemic
  • PVR >2/3 systemic without demonstrable vasoreactivity
  • Eisenmenger physiology with exercise-induced lower limb desaturation

Closure Method Selection

Device closure is the method of choice (Class I recommendation) 1. However, at age 29, be vigilant for:

  • Ductal calcification on CT/cardiac MRI (increases surgical risk significantly) 1, 6
  • Ductal aneurysm formation
  • Distorted anatomy precluding device placement

If device closure is not feasible due to calcification or anatomy, consult with a surgeon experienced in adult congenital heart disease before proceeding with surgical ligation 7, 6.

Critical Pitfalls to Avoid

  1. Don't assume typical PDA physiology: At 29 years old with septal flattening, this patient has evolved beyond simple left-to-right shunting. The RV pressure overload dominates the clinical picture 1.

  2. Don't skip vasoreactivity testing: If hemodynamics are borderline, vasoreactivity testing determines operability. Without it, you risk closing a PDA in someone with fixed pulmonary vascular disease, which can precipitate acute RV failure 1.

  3. Don't rely on echocardiography alone for PVR: When PAP is elevated on echo, cardiac catheterization is mandatory for accurate PVR calculation 1. Echo-derived estimates are insufficient for surgical decision-making.

  4. Don't miss Eisenmenger physiology: The presence of diastolic septal flattening suggests you're approaching or at the threshold where shunt reversal may occur. Check for differential cyanosis clinically and with pulse oximetry 5.

Prognostic Implications

The presence of D-shaped LV (eccentricity index ≥1.2 at end-diastole) carries independent prognostic significance, with increased risk of cardiovascular death and heart failure hospitalization 3. This finding alone justifies aggressive evaluation and intervention if hemodynamically appropriate.

Your patient requires expedited evaluation within 1-2 weeks, not routine follow-up, given the evidence of RV pressure overload at a relatively young age.

References

Related Questions

In a 2‑ to 4‑day‑old infant presenting with apnea, a machinery murmur, wide pulse pressure, and bilateral pulmonary edema on chest radiograph, what is the initial treatment?
In a 4‑month‑old infant with a patent ductus arteriosus (PDA) managed with medication who presents with cyanosis, irregular heart rhythm, and an S3 gallop, what is the most common cause of acute deterioration?
Is antibiotic prophylaxis indicated after transcatheter patent ductus arteriosus (PDA) closure, and if so, what regimen and duration?
What are the causes of hypertension after surgical closure of a patent ductus arteriosus (PDA)?
What is the appropriate management for a 1‑year‑11‑month‑old boy with macroglossia, macrocephaly (head circumference 51 cm), multiple pigmented skin patches, dysostosis, intellectual disability, a large inguinal hernia, chronic snoring, and mild patent ductus arteriosus (PDA) on echocardiogram, weighing 15.5 kg and 81 cm tall?
Can pyridostigmine be initiated in a patient after successful treatment of a small bowel obstruction?
Why does atopic dermatitis rarely involve the axillae and diaper (nappy) area?
What are the immediate postoperative care measures after hip surgical correction?
Which medications, categorized by mechanism of action, are used to manage atopic dermatitis in children?
What is the recommended workup and empiric antibiotic therapy for a hospitalized patient who develops hospital-acquired pneumonia?
Should I have a thyroidectomy for hyperthyroidism and will I need lifelong levothyroxine replacement therapy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.